156 related articles for article (PubMed ID: 35131538)
1. NAE modulators: A potential therapy for gastric carcinoma.
Liang Q; Liu M; Li J; Tong R; Hu Y; Bai L; Shi J
Eur J Med Chem; 2022 Mar; 231():114156. PubMed ID: 35131538
[TBL] [Abstract][Full Text] [Related]
2. Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions.
Fu DJ; Wang T
J Hematol Oncol; 2023 Jul; 16(1):87. PubMed ID: 37525282
[TBL] [Abstract][Full Text] [Related]
3. Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.
Xu GW; Toth JI; da Silva SR; Paiva SL; Lukkarila JL; Hurren R; Maclean N; Sukhai MA; Bhattacharjee RN; Goard CA; Medeiros B; Gunning PT; Dhe-Paganon S; Petroski MD; Schimmer AD
PLoS One; 2014; 9(4):e93530. PubMed ID: 24691136
[TBL] [Abstract][Full Text] [Related]
4. Overactivated neddylation pathway as a therapeutic target in lung cancer.
Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical Inhibition of Neddylation as Promising Treatments for Various Cancers.
Yin L; Xue Y; Shang Q; Zhu H; Liu M; Liu Y; Hu Q
Curr Top Med Chem; 2019; 19(12):1059-1069. PubMed ID: 30854973
[TBL] [Abstract][Full Text] [Related]
6. Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication.
Jiang Y; Jia L
Anticancer Agents Med Chem; 2015; 15(9):1127-33. PubMed ID: 25742093
[TBL] [Abstract][Full Text] [Related]
7. Phage display to identify Nedd8-mimicking peptides as inhibitors of the Nedd8 transfer cascade.
Zhao B; Zhang K; Villhauer EB; Bhuripanyo K; Kiyokawa H; Schindelin H; Yin J
Chembiochem; 2013 Jul; 14(11):1323-30. PubMed ID: 23824602
[TBL] [Abstract][Full Text] [Related]
8. DENEDDYLASE1 Protein Counters Automodification of Neddylating Enzymes to Maintain NEDD8 Protein Homeostasis in
Mergner J; Kuster B; Schwechheimer C
J Biol Chem; 2017 Mar; 292(9):3854-3865. PubMed ID: 28096463
[TBL] [Abstract][Full Text] [Related]
9. Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.
Flores-Martínez YA; Le-Trilling VTK; Trilling M
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452475
[TBL] [Abstract][Full Text] [Related]
10. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ.
Brownell JE; Sintchak MD; Gavin JM; Liao H; Bruzzese FJ; Bump NJ; Soucy TA; Milhollen MA; Yang X; Burkhardt AL; Ma J; Loke HK; Lingaraj T; Wu D; Hamman KB; Spelman JJ; Cullis CA; Langston SP; Vyskocil S; Sells TB; Mallender WD; Visiers I; Li P; Claiborne CF; Rolfe M; Bolen JB; Dick LR
Mol Cell; 2010 Jan; 37(1):102-11. PubMed ID: 20129059
[TBL] [Abstract][Full Text] [Related]
11. Discovery of candesartan cilexetic as a novel neddylation inhibitor for suppressing tumor growth.
Ni S; Chen X; Yu Q; Xu Y; Hu Z; Zhang J; Zhang W; Li B; Yang X; Mao F; Huang J; Sun Y; Li J; Jia L
Eur J Med Chem; 2020 Jan; 185():111848. PubMed ID: 31732254
[TBL] [Abstract][Full Text] [Related]
12. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
Soucy TA; Smith PG; Rolfe M
Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
[TBL] [Abstract][Full Text] [Related]
13. Small molecules targeting the NEDD8·NAE protein-protein interaction.
Lin CM; Jiang Z; Gao Z; Arancillo M; Burgess K
Chem Sci; 2020 Dec; 12(4):1535-1543. PubMed ID: 34163916
[TBL] [Abstract][Full Text] [Related]
14. MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy.
Nawrocki ST; Griffin P; Kelly KR; Carew JS
Expert Opin Investig Drugs; 2012 Oct; 21(10):1563-73. PubMed ID: 22799561
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 1,2,4-triazine-based derivatives as novel neddylation inhibitors and anticancer activity studies against gastric cancer MGC-803 cells.
Song J; Cui XX; Wu BW; Li D; Wang SH; Shi L; Zhu T; Zhang YB; Zhang SY
Bioorg Med Chem Lett; 2020 Jan; 30(2):126791. PubMed ID: 31740251
[TBL] [Abstract][Full Text] [Related]
16. A lysine-to-arginine mutation on NEDD8 markedly reduces the activity of cullin RING E3 ligase through the impairment of neddylation cascades.
Sui Y; Liu Y; Xu G
Biochem Biophys Res Commun; 2015 Jun; 461(4):653-8. PubMed ID: 25918018
[TBL] [Abstract][Full Text] [Related]
17. A novel NAE/UAE dual inhibitor LP0040 blocks neddylation and ubiquitination leading to growth inhibition and apoptosis of cancer cells.
Lu P; Guo Y; Zhu L; Xia Y; Zhong Y; Wang Y
Eur J Med Chem; 2018 Jun; 154():294-304. PubMed ID: 29843100
[TBL] [Abstract][Full Text] [Related]
18. The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy.
Soucy TA; Dick LR; Smith PG; Milhollen MA; Brownell JE
Genes Cancer; 2010 Jul; 1(7):708-16. PubMed ID: 21779466
[TBL] [Abstract][Full Text] [Related]
19. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
[TBL] [Abstract][Full Text] [Related]
20. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.
Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L
Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
